Skip to main content
Top
Published in: Inflammation 3/2014

01-06-2014

Peri-Infarct Zone Characterized by Cardiac Magnetic Resonance Imaging is Directly Associated with the Inflammatory Activity During Acute Phase Myocardial Infarction

Authors: Jose C. Quinaglia e Silva, Otavio Rizzi Coelho-Filho, Joalbo M. Andrade, Thiago Quinaglia, Rodrigo G. P. Modolo, Breno O. Almeida, Rob J. van der Geest, Michael Jerosch-Herold, Otavio Rizzi Coelho, Andrei C. Sposito, on behalf of the Brasilia Heart Study Group

Published in: Inflammation | Issue 3/2014

Login to get access

Abstract

Enhanced systemic inflammatory activity (SIA) during myocardial infarction (MI) and the extent of the peri-infarct zone characterized by cardiac magnetic resonance imaging (CMRi) are both associated with increased risk of life-threatening arrhythmias and sudden cardiac death. The present study investigated the existence of association between these two phenomena in 98 patients (55 ± 10 years) with ST segment elevation MI. Plasma levels of C-reactive protein (CRP), interleukin-2 (IL-2), and tumor necrosis factor (TNF) were measured on admission (D1) and on the fifth day post-MI (D5). CMRi was performed 2 weeks after MI to quantify peri-infarct zone (PIZ). Between D1 and D5, the increase in CRP (6.0 vs. 5.6 times; p = 0.02), IL-2 (3.6 vs. 3.4 times; p = 0.04) and tumor necrosis factor type α (TNF-α; 4.6 vs. 3.9 times; p = 0.001) were higher in patients with PIZ above the median than in the counterparts. PIZ was correlated with CRP-D5 (r = 0.69), delta-CRP (r = 0.7), IL-2-D5 (r = 0.5), delta-IL-2 (r = 0.6), TNF-α (r = 0.5), delta-TNF-α (r = 0.4; p = 0.0001). Enhanced activation of SIA during the acute phase of MI is directly related with generation of PIZ.
Literature
1.
go back to reference Frangogiannis, N.G., C.W. Smith, and M.L. Entman. 2002. The inflammatory response in myocardial infarction. Cardiovascular Research 53(1): 31–47.PubMedCrossRef Frangogiannis, N.G., C.W. Smith, and M.L. Entman. 2002. The inflammatory response in myocardial infarction. Cardiovascular Research 53(1): 31–47.PubMedCrossRef
2.
go back to reference Elmas, E., T. Popp, S. Lang, C.E. Dempfle, T. Kalsch, and M. Borggrefe. 2010. Sudden death: do cytokines and prothrombotic peptides contribute to the occurrence of ventricular fibrillation during acute myocardial infarction? International Journal of Cardiology 145(1): 118–119.PubMedCrossRef Elmas, E., T. Popp, S. Lang, C.E. Dempfle, T. Kalsch, and M. Borggrefe. 2010. Sudden death: do cytokines and prothrombotic peptides contribute to the occurrence of ventricular fibrillation during acute myocardial infarction? International Journal of Cardiology 145(1): 118–119.PubMedCrossRef
3.
go back to reference Pietila, K.O., A.P. Harmoinen, J. Jokiniitty, and A.I. Pasternack. 1996. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. European Heart Journal 17(9): 1345–1349.PubMedCrossRef Pietila, K.O., A.P. Harmoinen, J. Jokiniitty, and A.I. Pasternack. 1996. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. European Heart Journal 17(9): 1345–1349.PubMedCrossRef
4.
go back to reference Nian, M., P. Lee, N. Khaper, and P. Liu. 2004. Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research 94(12): 1543–1553.PubMedCrossRef Nian, M., P. Lee, N. Khaper, and P. Liu. 2004. Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research 94(12): 1543–1553.PubMedCrossRef
5.
go back to reference Saraste, A., K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, and L.M. Voipio-Pulkki. 1997. Apoptosis in human acute myocardial infarction. Circulation 95(2): 320–323.PubMedCrossRef Saraste, A., K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, and L.M. Voipio-Pulkki. 1997. Apoptosis in human acute myocardial infarction. Circulation 95(2): 320–323.PubMedCrossRef
6.
go back to reference Deneke, T., K.M. Muller, B. Lemke, T. Lawo, B. Calcum, M. Helwing, A. Mugge, and P.H. Grewe. 2005. Human histopathology of electroanatomic mapping after cooled-tip radiofrequency ablation to treat ventricular tachycardia in remote myocardial infarction. Journal of Cardiovascular Electrophysiology 16(11): 1246–1251.PubMedCrossRef Deneke, T., K.M. Muller, B. Lemke, T. Lawo, B. Calcum, M. Helwing, A. Mugge, and P.H. Grewe. 2005. Human histopathology of electroanatomic mapping after cooled-tip radiofrequency ablation to treat ventricular tachycardia in remote myocardial infarction. Journal of Cardiovascular Electrophysiology 16(11): 1246–1251.PubMedCrossRef
7.
go back to reference Schmidt, A., C.F. Azevedo, A. Cheng, S.N. Gupta, D.A. Bluemke, T.K. Foo, G. Gerstenblith, R.G. Weiss, E. Marban, G.F. Tomaselli, J.A. Lima, and K.C. Wu. 2007. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115(15): 2006–2014.PubMedCentralPubMedCrossRef Schmidt, A., C.F. Azevedo, A. Cheng, S.N. Gupta, D.A. Bluemke, T.K. Foo, G. Gerstenblith, R.G. Weiss, E. Marban, G.F. Tomaselli, J.A. Lima, and K.C. Wu. 2007. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115(15): 2006–2014.PubMedCentralPubMedCrossRef
8.
go back to reference Yan, A.T., A.J. Shayne, K.A. Brown, S.N. Gupta, C.W. Chan, T.M. Luu, M.F. Di Carli, H.G. Reynolds, W.G. Stevenson, and R.Y. Kwong. 2006. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114(1): 32–39.PubMedCrossRef Yan, A.T., A.J. Shayne, K.A. Brown, S.N. Gupta, C.W. Chan, T.M. Luu, M.F. Di Carli, H.G. Reynolds, W.G. Stevenson, and R.Y. Kwong. 2006. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114(1): 32–39.PubMedCrossRef
9.
go back to reference Simonetti, O.P., R.J. Kim, D.S. Fieno, H.B. Hillenbrand, E. Wu, J.M. Bundy, J.P. Finn, and R.M. Judd. 2001. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218(1): 215–223.PubMedCrossRef Simonetti, O.P., R.J. Kim, D.S. Fieno, H.B. Hillenbrand, E. Wu, J.M. Bundy, J.P. Finn, and R.M. Judd. 2001. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218(1): 215–223.PubMedCrossRef
10.
go back to reference Salton, C.J., M.L. Chuang, C.J. O’Donnell, M.J. Kupka, M.G. Larson, K.V. Kissinger, R.R. Edelman, D. Levy, and W.J. Manning. 2002. Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. Journal of the American College of Cardiology 39(6): 1055–1060.PubMedCrossRef Salton, C.J., M.L. Chuang, C.J. O’Donnell, M.J. Kupka, M.G. Larson, K.V. Kissinger, R.R. Edelman, D. Levy, and W.J. Manning. 2002. Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. Journal of the American College of Cardiology 39(6): 1055–1060.PubMedCrossRef
11.
go back to reference Alfakih, K., S. Reid, T. Jones, and M. Sivananthan. 2004. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. European Radiology 14(10): 1813–1822.PubMedCrossRef Alfakih, K., S. Reid, T. Jones, and M. Sivananthan. 2004. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. European Radiology 14(10): 1813–1822.PubMedCrossRef
12.
go back to reference Amado, L.C., B.L. Gerber, S.N. Gupta, D.W. Rettmann, G. Szarf, R. Schock, K. Nasir, D.L. Kraitchman, and J.A.C. Lima. 2004. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. Journal of the American College of Cardiology 44(12): 2383–2389.PubMedCrossRef Amado, L.C., B.L. Gerber, S.N. Gupta, D.W. Rettmann, G. Szarf, R. Schock, K. Nasir, D.L. Kraitchman, and J.A.C. Lima. 2004. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. Journal of the American College of Cardiology 44(12): 2383–2389.PubMedCrossRef
13.
go back to reference Suleiman, M., D. Aronson, S.A. Reisner, M.R. Kapeliovich, W. Markiewicz, Y. Levy, and H. Hammerman. 2003. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. American Journal of Medicine 115(9): 695–701.PubMedCrossRef Suleiman, M., D. Aronson, S.A. Reisner, M.R. Kapeliovich, W. Markiewicz, Y. Levy, and H. Hammerman. 2003. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. American Journal of Medicine 115(9): 695–701.PubMedCrossRef
14.
go back to reference Abbate, A., F.N. Salloum, E. Vecile, A. Das, N.N. Hoke, S. Straino, G.G. Biondi-Zoccai, J.E. Houser, I.Z. Qureshi, E.D. Ownby, E. Gustini, L.M. Biasucci, A. Severino, M.C. Capogrossi, G.W. Vetrovec, F. Crea, A. Baldi, R.C. Kukreja, and A. Dobrina. 2008. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117(20): 2670–2683.PubMedCrossRef Abbate, A., F.N. Salloum, E. Vecile, A. Das, N.N. Hoke, S. Straino, G.G. Biondi-Zoccai, J.E. Houser, I.Z. Qureshi, E.D. Ownby, E. Gustini, L.M. Biasucci, A. Severino, M.C. Capogrossi, G.W. Vetrovec, F. Crea, A. Baldi, R.C. Kukreja, and A. Dobrina. 2008. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117(20): 2670–2683.PubMedCrossRef
15.
go back to reference Hori, M., and K. Nishida. 2009. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovascular Research 81(3): 457–464.PubMedCrossRef Hori, M., and K. Nishida. 2009. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovascular Research 81(3): 457–464.PubMedCrossRef
16.
go back to reference Agosto, M., M. Azrin, K. Singh, A.S. Jaffe, and B.T. Liang. 2011. Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation myocardial infarction: a novel observation. Journal of the American College of Cardiology 57(2): 220–221.PubMedCrossRef Agosto, M., M. Azrin, K. Singh, A.S. Jaffe, and B.T. Liang. 2011. Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation myocardial infarction: a novel observation. Journal of the American College of Cardiology 57(2): 220–221.PubMedCrossRef
17.
go back to reference Condorelli, G., R. Roncarati, J. Ross Jr., A. Pisani, G. Stassi, M. Todaro, S. Trocha, A. Drusco, Y. Gu, M.A. Russo, G. Frati, S.P. Jones, D.J. Lefer, C. Napoli, and C.M. Croce. 2001. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proceedings of the National Academy of Sciences of the United States of America 98(17): 9977–9982.PubMedCentralPubMedCrossRef Condorelli, G., R. Roncarati, J. Ross Jr., A. Pisani, G. Stassi, M. Todaro, S. Trocha, A. Drusco, Y. Gu, M.A. Russo, G. Frati, S.P. Jones, D.J. Lefer, C. Napoli, and C.M. Croce. 2001. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proceedings of the National Academy of Sciences of the United States of America 98(17): 9977–9982.PubMedCentralPubMedCrossRef
18.
go back to reference Chen, Y., B. Pat, J. Zheng, L. Cain, P. Powell, K. Shi, A. Sabri, A. Husain, and L.J. Dell’italia. 2010. Tumor necrosis factor-alpha produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload. Journal of Molecular and Cellular Cardiology 49(1): 70–78.PubMedCentralPubMedCrossRef Chen, Y., B. Pat, J. Zheng, L. Cain, P. Powell, K. Shi, A. Sabri, A. Husain, and L.J. Dell’italia. 2010. Tumor necrosis factor-alpha produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload. Journal of Molecular and Cellular Cardiology 49(1): 70–78.PubMedCentralPubMedCrossRef
19.
go back to reference Schuleri, K.H., M. Centola, R.T. George, L.C. Amado, K.S. Evers, K. Kitagawa, A.L. Vavere, R. Evers, J.M. Hare, C. Cox, E.R. McVeigh, J.A. Lima, and A.C. Lardo. 2009. Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging. Journal of the American College of Cardiology 53(18): 1699–1707.PubMedCentralPubMedCrossRef Schuleri, K.H., M. Centola, R.T. George, L.C. Amado, K.S. Evers, K. Kitagawa, A.L. Vavere, R. Evers, J.M. Hare, C. Cox, E.R. McVeigh, J.A. Lima, and A.C. Lardo. 2009. Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging. Journal of the American College of Cardiology 53(18): 1699–1707.PubMedCentralPubMedCrossRef
20.
go back to reference Schuleri, K.H., M. Centola, K.S. Evers, A. Zviman, R. Evers, J.A. Lima, and A.C. Lardo. 2012. Cardiovascular magnetic resonance characterization of peri-infarct zone remodeling following myocardial infarction. Journal of Cardiovascular Magnetic Resonance 14: 24.PubMedCentralPubMedCrossRef Schuleri, K.H., M. Centola, K.S. Evers, A. Zviman, R. Evers, J.A. Lima, and A.C. Lardo. 2012. Cardiovascular magnetic resonance characterization of peri-infarct zone remodeling following myocardial infarction. Journal of Cardiovascular Magnetic Resonance 14: 24.PubMedCentralPubMedCrossRef
Metadata
Title
Peri-Infarct Zone Characterized by Cardiac Magnetic Resonance Imaging is Directly Associated with the Inflammatory Activity During Acute Phase Myocardial Infarction
Authors
Jose C. Quinaglia e Silva
Otavio Rizzi Coelho-Filho
Joalbo M. Andrade
Thiago Quinaglia
Rodrigo G. P. Modolo
Breno O. Almeida
Rob J. van der Geest
Michael Jerosch-Herold
Otavio Rizzi Coelho
Andrei C. Sposito
on behalf of the Brasilia Heart Study Group
Publication date
01-06-2014
Publisher
Springer US
Published in
Inflammation / Issue 3/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9784-y

Other articles of this Issue 3/2014

Inflammation 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.